全球基准标记市场

Fiducial Markers

出版日期: 2023年08月16日 | 出版商:

Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球基准标记市场将达到 1.664 亿美元

在不断变化的后 COVID-19 商业环境中，全球基准标记市场预计 2022 年为 1.09 亿美元，到 2030 年将调整为 1.664 亿美元，预计复合年增长率为 5.4%。 2010 年至 2030 年。金属是本报告分析的细分市场之一，预计复合年增长率为 6.5%，到分析期结束时将达到 7620 万美元。鑑于疫情后的持续復苏，未来八年聚合物细分市场的年复合成长率已调整为 4.9%。

美国市场预计增长2970万美元，中国复合年增长率为9.5%

到 2022 年，美国基准标记市场预计将达到 2970 万美元。中国是世界第二大经济体，预计在2022年至2030年的分析期间将以9.5%的年复合成长率增长，预计到2030年市场规模将达到3780万美元。其他值得注意的地域市场包括日本和加拿大，预计 2022 年至 2030 年将分别增长 2.6% 和 4.1%。在欧洲，德国预计年复合成长率约为 3.6%。

受访企业示例

Beekley Corporation
Best Medical International, Inc.
Boston Scientific Corporation
Carbon Medical Technologies
CIVCO Radiotherapy
Eckert & Ziegler
IBA
Innomedicus AG
Innovative Oncology Solutions
IZI Medical Products
JJ-Medtech
Meditronix Corporation
Medtronic
Nanovi A/S
Naslund Medical AB
QFIX
QlRad Inc.
Seedos Ltd
Stellar Medical
Varian Medical Systems, Inc.

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Fiducial Markers Market to Reach $166.4 Million by 2030

In the changed post COVID-19 business landscape, the global market for Fiducial Markers estimated at US$109 Million in the year 2022, is projected to reach a revised size of US$166.4 Million by 2030, growing at aCAGR of 5.4% over the period 2022-2030. Metal, one of the segments analyzed in the report, is projected to record 6.5% CAGR and reach US$76.2 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Polymer segment is readjusted to a revised 4.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $29.7 Million, While China is Forecast to Grow at 9.5% CAGR

The Fiducial Markers market in the U.S. is estimated at US$29.7 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$37.8 Million by the year 2030 trailing a CAGR of 9.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 4.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Select Competitors (Total 42 Featured) -

Beekley Corporation
Best Medical International, Inc.
Boston Scientific Corporation
Carbon Medical Technologies
CIVCO Radiotherapy
Eckert & Ziegler
IBA
Innomedicus AG
Innovative Oncology Solutions
IZI Medical Products
JJ-Medtech
Meditronix Corporation
Medtronic
Nanovi A/S
Naslund Medical AB
QFIX
QlRad Inc.
Seedos Ltd
Stellar Medical
Varian Medical Systems, Inc.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Fiducial Markers - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 2: World Historic Review for Fiducial Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 3: World 16-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Metal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 5: World Historic Review for Metal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 6: World 16-Year Perspective for Metal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 8: World Historic Review for Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 9: World 16-Year Perspective for Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Cancer Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 11: World Historic Review for Cancer Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 12: World 16-Year Perspective for Cancer Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Hospitals & Outpatient Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 14: World Historic Review for Hospitals & Outpatient Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 15: World 16-Year Perspective for Hospitals & Outpatient Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- TABLE 16: World Recent Past, Current & Future Analysis for Independent Radiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 17: World Historic Review for Independent Radiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 18: World 16-Year Perspective for Independent Radiotherapy Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- TABLE 19: World Recent Past, Current & Future Analysis for CT / CBCT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 20: World Historic Review for CT / CBCT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 21: World 16-Year Perspective for CT / CBCT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- TABLE 22: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 23: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 24: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- TABLE 25: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 26: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 27: World 16-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- TABLE 28: World Recent Past, Current & Future Analysis for Radiotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 29: World Historic Review for Radiotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 30: World 16-Year Perspective for Radiotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
- TABLE 31: World Fiducial Markers Market Analysis of Annual Sales in US$ for Years 2014 through 2030
- TABLE 32: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 33: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 34: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- TABLE 35: USA Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 36: USA Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 37: USA 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 38: USA Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 39: USA Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 40: USA 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 41: USA Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 43: USA 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
CANADA
- TABLE 44: Canada Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 45: Canada Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 46: Canada 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 47: Canada Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 48: Canada Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 49: Canada 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 50: Canada Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 52: Canada 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
JAPAN
- Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- TABLE 53: Japan Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 54: Japan Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 55: Japan 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 56: Japan Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 57: Japan Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 58: Japan 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 59: Japan Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 60: Japan Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 61: Japan 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
CHINA
- Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- TABLE 62: China Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 63: China Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 64: China 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 65: China Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 66: China Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 67: China 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 68: China Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 69: China Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 70: China 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
EUROPE
- Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- TABLE 71: Europe Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 72: Europe Historic Review for Fiducial Markers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 73: Europe 16-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
- TABLE 74: Europe Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 75: Europe Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 76: Europe 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 77: Europe Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 79: Europe 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 80: Europe Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 81: Europe Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 82: Europe 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
FRANCE
- Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- TABLE 83: France Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 84: France Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 85: France 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 86: France Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 87: France Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 88: France 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 89: France Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 90: France Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 91: France 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
GERMANY
- Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- TABLE 92: Germany Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 93: Germany Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 94: Germany 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 95: Germany Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 96: Germany Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 97: Germany 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 98: Germany Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 99: Germany Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 100: Germany 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
ITALY
- TABLE 101: Italy Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 102: Italy Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 103: Italy 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 104: Italy Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 105: Italy Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 106: Italy 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 107: Italy Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 108: Italy Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 109: Italy 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
UNITED KINGDOM
- Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- TABLE 110: UK Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 111: UK Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 112: UK 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 113: UK Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 114: UK Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 115: UK 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 116: UK Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 117: UK Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 118: UK 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
SPAIN
- TABLE 119: Spain Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 120: Spain Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 121: Spain 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 122: Spain Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 123: Spain Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 124: Spain 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 125: Spain Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 126: Spain Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 127: Spain 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
RUSSIA
- TABLE 128: Russia Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 129: Russia Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 130: Russia 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 131: Russia Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 132: Russia Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 133: Russia 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 134: Russia Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 135: Russia Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 136: Russia 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
REST OF EUROPE
- TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 138: Rest of Europe Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 139: Rest of Europe 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 141: Rest of Europe Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 142: Rest of Europe 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 144: Rest of Europe Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 145: Rest of Europe 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
ASIA-PACIFIC
- Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 147: Asia-Pacific Historic Review for Fiducial Markers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 148: Asia-Pacific 16-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
- TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 150: Asia-Pacific Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 151: Asia-Pacific 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 153: Asia-Pacific Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 154: Asia-Pacific 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 156: Asia-Pacific Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 157: Asia-Pacific 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
AUSTRALIA
- Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
- TABLE 158: Australia Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 159: Australia Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 160: Australia 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 161: Australia Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 162: Australia Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 163: Australia 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 164: Australia Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 165: Australia Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 166: Australia 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
INDIA
- Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
- TABLE 167: India Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 168: India Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 169: India 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 170: India Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 171: India Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 172: India 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 173: India Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 174: India Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 175: India 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
SOUTH KOREA
- TABLE 176: South Korea Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 177: South Korea Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 178: South Korea 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 179: South Korea Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 180: South Korea Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 181: South Korea 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 182: South Korea Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 183: South Korea Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 184: South Korea 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
REST OF ASIA-PACIFIC
- TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 186: Rest of Asia-Pacific Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 189: Rest of Asia-Pacific Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 192: Rest of Asia-Pacific Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
LATIN AMERICA
- Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
- TABLE 194: Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 195: Latin America Historic Review for Fiducial Markers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 196: Latin America 16-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
- TABLE 197: Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 198: Latin America Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 199: Latin America 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 200: Latin America Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 201: Latin America Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 202: Latin America 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 203: Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 204: Latin America Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 205: Latin America 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
ARGENTINA
- TABLE 206: Argentina Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 207: Argentina Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 208: Argentina 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 209: Argentina Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 210: Argentina Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 211: Argentina 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 212: Argentina Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 213: Argentina Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 214: Argentina 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
BRAZIL
- TABLE 215: Brazil Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 216: Brazil Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 217: Brazil 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 218: Brazil Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 219: Brazil Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 220: Brazil 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 221: Brazil Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 222: Brazil Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 223: Brazil 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
MEXICO
- TABLE 224: Mexico Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 225: Mexico Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 226: Mexico 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 227: Mexico Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 228: Mexico Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 229: Mexico 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 230: Mexico Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 231: Mexico Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 232: Mexico 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
REST OF LATIN AMERICA
- TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 234: Rest of Latin America Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 235: Rest of Latin America 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 237: Rest of Latin America Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 238: Rest of Latin America 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 240: Rest of Latin America Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 241: Rest of Latin America 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
MIDDLE EAST
- Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
- TABLE 242: Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
- TABLE 243: Middle East Historic Review for Fiducial Markers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 244: Middle East 16-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
- TABLE 245: Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 246: Middle East Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 247: Middle East 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 248: Middle East Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 249: Middle East Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 250: Middle East 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 251: Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 252: Middle East Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 253: Middle East 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
IRAN
- TABLE 254: Iran Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 255: Iran Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 256: Iran 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 257: Iran Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 258: Iran Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 259: Iran 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 260: Iran Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 261: Iran Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 262: Iran 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
ISRAEL
- TABLE 263: Israel Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 264: Israel Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 265: Israel 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 266: Israel Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 267: Israel Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 268: Israel 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 269: Israel Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 270: Israel Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 271: Israel 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
SAUDI ARABIA
- TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 273: Saudi Arabia Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 274: Saudi Arabia 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 276: Saudi Arabia Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 277: Saudi Arabia 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 279: Saudi Arabia Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 280: Saudi Arabia 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
UNITED ARAB EMIRATES
- TABLE 281: UAE Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 282: UAE Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 283: UAE 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 284: UAE Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 285: UAE Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 286: UAE 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 287: UAE Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 288: UAE Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 289: UAE 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
REST OF MIDDLE EAST
- TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 291: Rest of Middle East Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 292: Rest of Middle East 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 294: Rest of Middle East Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 295: Rest of Middle East 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 297: Rest of Middle East Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 298: Rest of Middle East 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030
AFRICA
- Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
- TABLE 299: Africa Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 300: Africa Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 301: Africa 16-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2014, 2023 & 2030
- TABLE 302: Africa Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 303: Africa Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 304: Africa 16-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2014, 2023 & 2030
- TABLE 305: Africa Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
- TABLE 306: Africa Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2021 and % CAGR
- TABLE 307: Africa 16-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2014, 2023 & 2030